Free Trial
NYSE:ENZ

Enzo Biochem (ENZ) Stock Price, News & Analysis

Enzo Biochem logo
$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Enzo Biochem Stock (NYSE:ENZ)

Key Stats

Today's Range
$0.31
$0.40
50-Day Range
$0.33
$0.33
52-Week Range
$0.25
$1.20
Volume
4.12 million shs
Average Volume
169,979 shs
Market Capitalization
$17.03 million
P/E Ratio
N/A
Dividend Yield
123.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ENZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter.

ENZ Stock News Headlines

ENZB - Enzo Biochem Inc Dividends - Morningstar
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Enzo Biochem: Fiscal Q3 Earnings Snapshot
See More Headlines

ENZ Stock Analysis - Frequently Asked Questions

Enzo Biochem's stock was trading at $0.7143 on January 1st, 2025. Since then, ENZ stock has decreased by 54.5% and is now trading at $0.3250.

Enzo Biochem, Inc. (NYSE:ENZ) released its quarterly earnings results on Monday, March, 17th. The medical research company reported ($0.02) earnings per share for the quarter. The medical research company earned $7.33 million during the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative trailing twelve-month return on equity of 7.96%.

Shares of ENZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzo Biochem investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Virgin Galactic (SPCE) and OneLife Technologies (OLMM).

Company Calendar

Last Earnings
3/17/2025
Today
7/04/2025
Fiscal Year End
7/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NYSE:ENZ
Employees
520
Year Founded
1976

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.08 million
Pretax Margin
-23.79%

Debt

Sales & Book Value

Annual Sales
$29.09 million
Price / Cash Flow
N/A
Book Value
$1.09 per share
Price / Book
0.30

Miscellaneous

Free Float
46,288,000
Market Cap
$17.03 million
Optionable
Optionable
Beta
1.19

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:ENZ) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners